Vasoactive vasodilating drugs (VVDs) have differential effects on the progression of systemic sclerosis-associated interstitial lung disease (SSc-ILD), according to a post hoc analysis of ...
MedPage Today on MSN
Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis
Clinical worsening also occurred less frequently with treprostinil ...
Most VVD in clinical trials have been shown to exert anti-fibrotic effects – but findings are mixed around whether they also improve pulmonary function tests and prevent progression of SSc-associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results